Please login to the form below

Not currently logged in
Email:
Password:

Gyros Protein Technologies appoints chairman

Dr Frank Witney brings experience from Affymetrix and Dionex

Gyros Protein Technologies Dr Frank WitneySwedish Gyros Protein Technologies has appointed Dr Frank Witney as the new chairman of its board, succeeding David Patteson.

Dr Witney brings over 30 years of leadership experience in the life sciences industry, most recently having served as president and chief executive officer of Affymetrix.

He has held a number of executive roles in recent years, including serving as president and chief executive of both Dionex and Panomics, and was Packard Biosciences' chief operating officer before becoming president of life sciences after the firm's acquisition by Perkin Elmer.

Dan Calvo, Gyros Protein Technologies' chief executive, said: “We are delighted that Frank has joined as chairman.

“He brings with him a wealth of experience and knowledge in the field, and his guidance will be invaluable as we work to build Gyros Protein Tehcnologies following the merger earlier this year.”

23rd June 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics